Home › Prostate Cancer › Michigan
Prostate Cancer clinical trials in Michigan
56 studies for Prostate Cancer are looking for participants at sites in Michigan.
Cities in Michigan
- Ann Arbor27 studies
- Detroit22 studies
- Grand Rapids19 studies
- Lansing10 studies
- Farmington Hills8 studies
- Clinton Township8 studies
- Canton8 studies
- Flint7 studies
- Waterford7 studies
- Warren7 studies
- Livonia7 studies
- Dearborn6 studies
- Saginaw5 studies
- Troy5 studies
- Jackson4 studies
- Kalamazoo3 studies
- Wyoming3 studies
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- and 8 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Bronson Battle Creek, Battle Creek
- Henry Ford Cancer Institute-Downriver, Brownstown
- and 17 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT07200830A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- and 68 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health Medical Center - Brighton, Brighton
- and 32 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382Precision-Based Genomics in Prostate Cancer
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 18 to 120 · Men · Updated Sep 28, 2026 · NCT04706663Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Ann Arbor
- Research Site, Detroit
RecruitingPhase 1/2
Ages 18 to 130 · Men · Updated Sep 25, 2026 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- South Texas Accelerated Research Therapeutics, LLC (START), Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Henry Ford Hospital ( Site 0015), Detroit
- Cancer and Hematology Centers of Western Michigan ( Site 0005), Grand Rapids
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06136650A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Start Midwest, Grand Rapids
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT07746713This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Michigan Institute of Urology, PC, Troy
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Midwest, Grand Rapids
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07719361A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Barbara Ann Karmanos Cancer Institute, Detroit
- BAMF Health Inc., Grand Rapids
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Barbara Ann Karmanos Cancer Institute, Lansing
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Karmanos Cancer Institute, Detroit
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06855277Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
- BAMF Health, Grand Rapids
RecruitingPhase 2/3
Ages 18 and older · Men · Updated Sep 21, 2026 · NCT07831824Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- University of Michigan ( Site 0005), Ann Arbor
- Henry Ford Hospital ( Site 0035), Detroit
- Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 16, 2026 · NCT07332455A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- BAMF Health, Grand Rapids
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 15, 2026 · NCT07581184Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Wayne State University, Detroit
Recruiting
Ages 18 and older · Men · Updated Sep 14, 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- BAMF Health, Grand Rapids
- Corewell Health, Grand Rapids
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health Medical Center - Brighton, Brighton
- and 21 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Research Site, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT07192614Prostate Active Surveillance Study
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 21 and older · Men · Updated Sep 2, 2026 · NCT00756665The Vanguard Study: Testing a New Way to Screen for Cancer
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Health Center - Brownstown, Brownstown
- Henry Ford Health Center - Chesterfield, Chesterfield
- and 13 more
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Sep 2, 2026 · NCT06995898COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- Rogel Cancer Center, Ann Arbor
RecruitingObservational study
Ages 18 and older · Men · Updated Aug 27, 2026 · NCT07050433AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Grand Rapids
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 26, 2026 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Henry Ford, Novi
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 24, 2026 · NCT07745361A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Karmanos Cancer Institute, Detroit
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Aug 20, 2026 · NCT06785636EDRN Prostate MRI Biomarker Study
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT03784924Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- University of Michigan Health, Ann Arbor
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 14, 2026 · NCT04812366SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
- University of Michigan Comprehensive Cancer Center, Ann Arbor
RecruitingObservational study
Ages 18 and older · Men · Updated Jul 27, 2026 · NCT07096999Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- McLaren Cancer Institute-Bay City, Bay City
- and 19 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Karmanos, Detroit
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT05413421Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
- Karmanos Cancer Institute, Detroit
Recruiting
Ages 20 to 79 · All sexes · Updated Jun 23, 2026 · NCT07436078Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- McLaren Proton Therapy Center, Flint
Recruiting
Ages 18 and older · Men · Updated Jun 17, 2026 · NCT00969111Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Ann Arbor Healthcare System, Ann Arbor
RecruitingPhase 2
Ages 18 and older · Men · Updated Jun 15, 2026 · NCT05422911Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
- University of Michigan Rogel Cancer Center, Ann Arbor
RecruitingObservational study
Ages 35 to 70 · Men · Updated Jun 12, 2026 · NCT07645391From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.